Vor Biopharma Inc.
- Last sale
- Nov 12, 2026 · -3.91%
- Market cap
- $1.19B
- 61.43M shares
- Filings
- 466
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+383.8% FY25 yoy
- $1.19B
- —
- —
- —
- -12.11%
- 0.00%
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $321,532,000 | reported | |
| FY 2024 | 2024-12-31 | $93,310,000 | reported | |
| FY 2023 | 2023-12-31 | $94,315,000 | reported | |
| FY 2022 | 2022-12-31 | $64,550,000 | reported | |
| FY 2021 | 2021-12-31 | $47,529,000 | reported | |
| FY 2020 | 2020-12-31 | $31,618,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $0.00 | — | $0.00 | — | 48.85M sh | −60.9% | — |
| FY2024 | $0.00 | — | $0.00 | — | 124.85M sh | +83.2% | — |
| FY2023 | $0.00 | — | $0.00 | — | 68.17M sh | +2.7% | — |
| FY2022 | $0.00 | — | $0.00 | — | 66.37M sh | +77.1% | — |
| FY2021 | $0.00 | — | $0.00 | — | 37.49M sh | +7,322.4% | — |
Biological products, except diagnostic substances
Vor Biopharma Inc. is the 45th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
IMCRImmunocore Holdings plc$400.0M29.0%8.9%$1.6BALVOAlvotech$586.3M19.7%4.8%$1.5BNVAXNovavax Inc$1.1B64.7%39.2%$1.4BINBXInhibrx Biosciences, Inc.$1.3M550.0%10,773.5%$1.3BTSHATaysha Gene Therapies, Inc.$9.8M17.3%1,115.3%$1.3B
VORVor Biopharma Inc. (this company)———$1.2B
ODTXOdyssey Therapeutics, Inc.———$969.5MIMTXImmatics N.V.———$871.5MMGTXMeiraGTx Holdings plc$81.4M144.6%140.3%$858.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Vor Biopharma Inc. · CIK 1817229 · Engraved from SEC EDGAR